News Focus
News Focus
icon url

DewDiligence

03/13/23 11:06 AM

#245865 RE: Biowatch #245863

PFE-SGEN CC slides:

https://s28.q4cdn.com/781576035/files/doc_presentation/2023/03/Pfizer-Seagen-Analyst-Call-Slides-Final-03-13-23-_Update.pdf

The buyout price of $229/sh cash is a 42% premium to SGEN’s “unaffected” 2/24/23 closing price. The nominal deal value is $43B including assumption of debt.

The deal is expected to close in late 2023 or 2024 due to a lengthy review by antitrust regulators.
icon url

MiamiGent

03/13/23 11:57 AM

#245869 RE: Biowatch #245863

Fantastic! I woulda made a bundle, lol
icon url

vinmantoo

03/13/23 12:01 PM

#245870 RE: Biowatch #245863

PFE to buy SGEN for $43 billion, $229/sh



As a long time SGEN shareholder this pleases me. Still has to pass regulatory scrutiny.
icon url

DewDiligence

12/12/23 9:58 AM

#250036 RE: Biowatch #245863

PFE-SGEN merger will close December 14:

https://finance.yahoo.com/news/pfizer-receives-required-regulatory-approvals-114500644.html

PFE made a trivial concession to get FTC approval for the deal: PFE will donate royalties received from Merck KGaA on Bavencio sales to the AACR.